AOD9604
5mg69,99 € incl. VAT
A modified fragment of human growth hormone (residues 176-191) investigated for its lipolytic properties, cartilage regeneration potential, and favorable safety profile without effects on blood glucose or IGF-1 levels.
All presented information is based on scientific publications which can be found at the end of product description below.
Out of stock
Email when stock available
Batch-level quality proof
Every research peptide is supplied as a sealed, clearly labelled vial. Batch-level Certificate of Analysis information and purity testing records are published online for every production lot, not shipped as research paperwork in the parcel.
Sealed vial
Clear label, lot traceability, protective packaging.
Certificate of Analysis for every lot
Listed report available for batch XD-A05-PO07. Purity shown: 98.6%.
RUO boundary
Not for human or veterinary use, no protocol or dosing advice.
Product specifications
| Quantity | 5 mg |
|---|---|
| Unit | 1 Vial |
| Purity data | ≥98% |
| Salt form | Acetate |
| Sequence | Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe Disulfide bridge Cys7-Cys14 |
| Molecular mass | 1815.12 |
| CAS number | 221231-10-3 |
| Solubility | Sterile / Bacteriostatic water 2,5ml/vial |
Description
Research Use Only. This material is supplied for in-vitro laboratory research by qualified professionals. It is not a medicine, supplement, cosmetic ingredient or veterinary product, and it is not for human or animal consumption. The research summary below describes published scientific literature; it is not a claim of effect, benefit or suitability for any person.
AOD-9604 is a lab-made peptide, 15 amino acids long, taken from the C-terminal portion of human growth hormone (hGH 176-191) and altered so its fat-metabolism activity is more pronounced. Supplied as lyophilised material for in-vitro laboratory research.
Research context
Published work that mentions or examines AOD-9604 generally shows up in a few research areas: models of adipose tissue and energy balance, studies using cartilage or other joint-related tissues, and investigations looking at cardiovascular markers.
The product is intended for scientific research and development purposes only. Chemical substances shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals. Intended only for in-vitro research, such as Receptor-ligand binding studies, Enzyme activity assays, Cell proliferation assays, Cell signaling assays, Epitope mapping, etc. Do not order for personal use, clinical use, injection, compounding, resale as a supplement, or any project that requires a specific assay not shown for the relevant batch.
Frequently asked questions
What is AOD9604 used for in research?
AOD9604 is a synthetic research peptide used in preclinical and in-vitro literature. Peptra Labs supplies it strictly for laboratory research use only, not for human or veterinary use.
Can I buy AOD9604 in Europe from Peptra Labs?
Peptra Labs supplies AOD9604 research peptide for European laboratory buyers. Orders contain a sealed, clearly labelled vial, with EU shipping and online Certificate of Analysis information for every lot. No physical Certificate of Analysis or research papers are promised inside the parcel.
Does AOD9604 have a Certificate of Analysis?
Batch-level Certificate of Analysis information is available for every lot through Peptra Labs lab reports. Use the online report to review the batch number, HPLC purity data, test method, and source link, then compare the batch information with the vial label.
What purity signals should I check for AOD9604?
Check the vial label, batch number, available HPLC purity data, Certificate of Analysis source, supplier identity, storage guidance, and the absence of human-use claims. A useful supplier page should make these checks clear instead of relying on generic purity promises.
How is AOD9604 stored in research labs?
Lyophilised AOD9604 is typically stored sealed, protected from light, and cold for long-term laboratory storage. After laboratory preparation for in-vitro work, follow your institution's validated handling procedure and avoid repeated freeze-thaw cycles.
Human or veterinary use?
No. AOD9604 from Peptra Labs is supplied strictly as laboratory research material and must not be used as a human or veterinary product.
Batch test records
2 test records published for this compound. Check the batch number on your vial against the list below.
- Tested
- 8 Sep 2026
- Assay
- Purity, identity and endotoxin
- Purity
- 98.6%
- Tested
- 8 Sep 2026
- Assay
- Purity, identity and endotoxin
- Purity
- 99.1%
You Might Also Like
A modified GHRH analogue featuring a Drug Affinity Complex for extended half-life, producing sustained GH and IGF-1 elevations while preserving physiological pulsatility.
- Purity tested
A modified IGF-1 with extended half-life and enhanced potency due to reduced IGFBP binding, valuable for cell proliferation, muscle biology, and metabolic signaling research.
- Purity tested
The first selective growth hormone secretagogue that stimulates GH release without affecting ACTH, cortisol, or prolactin levels, investigated for bone health, muscle preservation, and gastrointestinal recovery.
- Purity tested
A truncated kisspeptin neuropeptide that potently activates KISS1R, serving as a key regulator of the hypothalamic-pituitary-gonadal axis with applications in reproductive endocrinology research.
- Purity tested
A mitochondrial-derived peptide that translocates to the nucleus during metabolic stress, enhancing glucose metabolism, insulin sensitivity, and bone health through AMPK-dependent mechanisms.
- Purity tested
- Endotoxin tested
A selective ERRα/γ agonist functioning as an exercise mimetic, activating mitochondrial biogenesis and oxidative metabolism pathways with implications for metabolic disease research.
- Purity tested
A synthetic GHRH analogue (1-44) with FDA approval for HIV-associated lipodystrophy, investigated for visceral fat reduction, hepatic steatosis, and cognitive function enhancement.
- Purity tested
- Endotoxin tested
A synthetic dual agonist at the GIP and GLP-1 receptors, developed by Eli Lilly. Examined in the published literature on incretin signalling, glucose handling and energy balance.
- Purity tested